financetom
Business
financetom
/
Business
/
Sun Life US dental business has quarterly loss but on track to earn $100 million in 2025
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sun Life US dental business has quarterly loss but on track to earn $100 million in 2025
Aug 13, 2024 10:46 AM

TORONTO (Reuters) - Sun Life Financial Inc CEO Kevin Strain said on Tuesday the company's U.S. dental insurance business was improving after losing money in the latest quarter, and was on track to hit its goal for $100 million in earnings in that segment in 2025.

The Canadian insurer's shares were up about 5% in mid-day trading in Toronto after its second quarter earnings topped expectations.

The dental segment posted a loss for the second quarter hit by Medicaid redeterminations that pressure Medicaid and Medicare Advantage sales leading to a 5% fall in the US segment's core earnings.

As more Medicaid contracts are repriced along with broader expense reductions, the segment is expected to see improvements.

About 90% of Medicaid contracts are expected to be repriced this year, the company said.

"We still think that the U.S. is a good long term growth market for us in both the group benefit side (and) in the asset management side under both MFS and SLC," Strain said in an interview.

Sun Life acquired dental benefits provider DentaQuest as part of its strategy to grow its presence in the U.S., which now accounts for roughly a fifth of its overall undelying income.

"We would look at expanding growth there (U.S.), as well as in Asia," he said, adding that US is a growing segment with potential in both insurance and asset management.

Jefferies analyst John Aiken noted that while the U.S. dental business faced challenges, it provides "upside potential that should be easily recognized with the management actions taken to date."

Sun Life's Tuesday gains took its year-to-date performance to positive territory. Rival Manulife's shares have gained 18.8% so far this year.

(Reporting by Nivedita Balu in Toronto)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
4D Molecular Reports Regulatory Updates on 4D-710 For Cystic Fibrosis
4D Molecular Reports Regulatory Updates on 4D-710 For Cystic Fibrosis
Mar 28, 2024
02:32 PM EDT, 03/28/2024 (MT Newswires) -- 4D Molecular Therapeutics ( FDMT ) said it conducted initial pivotal study interactions with the US Food and Drug Administration and European Medicines Agency over its development plans for 4D-710 for treatment of cystic fibrosis lung disease. We are encouraged by our productive interactions with the FDA and EMA, said CEO David Kirn....
Kitchen sponge maker Scrub Daddy explores sale, sources say
Kitchen sponge maker Scrub Daddy explores sale, sources say
Mar 28, 2024
March 28 (Reuters) - Scrub Daddy, the kitchen sponge maker that gained popularity after securing an investment on U.S. TV show Shark Tank, is exploring options that include a sale of the company, according to people familiar with the matter. Scrub Daddy, which is backed by entrepreneur Lori Greiner, has hired JPMorgan Chase ( JPM ) to advise on whether...
Market Chatter: Nutrien Considers Divestments, Management Changes in South American Operations
Market Chatter: Nutrien Considers Divestments, Management Changes in South American Operations
Mar 28, 2024
02:33 PM EDT, 03/28/2024 (MT Newswires) -- Nutrien ( NTR ) is considering strategic changes in South America over significant losses in the region including divestments, new management and stopping its acquisition spree in Brazil, Reuters reported Thursday, citing sources with direct knowledge of the matter. The company has already separated Brazil from the rest of its regional operations and...
CANADA ECONOMICS FEATURE: CIBC's Avery Shenfeld On the Productivity Malaise
CANADA ECONOMICS FEATURE: CIBC's Avery Shenfeld On the Productivity Malaise
Mar 28, 2024
02:33 PM EDT, 03/28/2024 (MT Newswires) -- Avery Shenfeld noted Thursday this week's speech by the Bank of Canada's Carolyn Rogers drew useful attention to the symptoms of Canada's productivity malaise. But, he said, we're still left without much progress towards a diagnosis, the first step towards a cure, and that might explain why public policy efforts in this area...
Copyright 2023-2025 - www.financetom.com All Rights Reserved